Background: Peripheral arterial disease (PAD) is linked to a decrease in functional ability as well as a higher risk of cardiovascular morbidity and mortality. Despite its widespread incidence, links to mortality, morbidity, and impaired quality of life, PAD is underdiagnosed and undertreated. Aims and Objectives: The aim of the study was to review the available literature on this subject and analyze the mode of presentation, symptoms, signs, age incidence and results of conservative management and angioplasty, and stenting as measured by limb salvage and amputation rates. Materials and Methods: The study was carried out on 40 patients chosen from the patients admitted in Government General Hospital, Nizamabad, with a diagnosis of peripheral vascular disease from May 2019 to April 2022. Results: It is revealed from the study that out of 28 patients with Atherosclerosis, 10 patients weremanaged conservatively, 12 underwent primary amputation, two secondary amputation, and four patients were managed with angioplasty and stenting of anterior tibial artery. Among the eight patients with Thromboangiitis Obliterans, six patients were managed conservatively, and two patients underwent primary amputations. Two patients with acute embolic disease were referred to higher center for embolectomy and remaining two patients with inconclusive etiology were managed conservatively. Conclusion: Atherosclerosis is mainly a disease of old age but now the trend is moving towards earlier decades as well. Hence, risk factor modification and awareness remain the best method of prevention. Embolectomy should be carried out aggressively in all cases with potentially salvageable limbs.
Background: Pancreatitis is described as any inflammation that manifests in acute or chronic forms in the pancreas. Acute pancreatitis (AP) is a quick attack that results in pancreatic inflammation and affects the peripancreatic tissue and surrounding organ. Aims and Objectives: This study aims to evaluate lipid profile tests in AP patients. Materials and Methods: The present study was conducted in the Department of General Surgery, Government Medical College, Nizamabad, India, prospectively from July 2019 to May 2022. In our study, we enrolled 100 patients between the age of 20 and 60 and divided them into two groups by random selection. We chose 50 consecutive cases of pancreatitis for the study group and 50 other hospitalized patients for the control group. Results: Mean age of the case group and control group was found to be 39.17±7.42 and 41.92±9.1, respectively. We observed that the peak incidence of pancreatitis occurred between the ages of 40 and 70, with a male predominance in all age categories. When compared to control, low-density lipoprotein cholesterol (P=0.715), total cholesterol (P=0.3124), high-density lipoprotein cholesterol (HDL-C) (0.164), non-HDL-C (0.2436), and triglyceride (P=0.1266) of the study group were found to be statistically non-significant. Conclusion: It is determined that serum lipid profile and pancreatitis are frequently linked. To reduce the risk of developing this disease, prevent its underlying complications, and manage the possibility of subsequent recurrences, patients with the aforementioned risk factors should be assessed for any changes in their serum lipid profile. If such an alteration is discovered, they should be treated with antilipidemic medications, dietary modification, lifestyle change, and physical activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.